Equities

Progyny Inc

PGNY:NSQ

Progyny Inc

Actions
Health CareHealth Care Providers
  • Price (USD)16.61
  • Today's Change0.08 / 0.48%
  • Shares traded1.24m
  • 1 Year change-43.71%
  • Beta1.3698
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments371189119
Total Receivables, Net242240135
Total Inventory------
Prepaid expenses274.494.56
Other current assets, total------
Total current assets640434259
Property, plant & equipment, net281513
Goodwill, net121212
Intangibles, net00.100.60
Long term investments------
Note receivable - long term------
Other long term assets3.403.992.94
Total assets757543358
LIABILITIES
Accounts payable12510961
Accrued expenses594435
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1.186.482.17
Total current liabilities18616099
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total176.487.42
Total liabilities203166106
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital462350255
Retained earnings (accumulated deficit)9028(2.42)
Treasury stock - common(1.01)(1.01)(1.01)
Unrealized gain (loss)------
Other equity, total2.820.50(0.09)
Total equity553377252
Total liabilities & shareholders' equity757543358
Total common shares outstanding969391
Treasury shares - common primary issue0.620.620.62
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.